| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Aclaris Therapeutics, Inc. | Chief Scientific Officer | Employee Stock Option (right to buy) | 510K | Aug 1, 2025 | Direct | ||
| Aclaris Therapeutics, Inc. | Chief Scientific Officer | Restricted Stock Units | 146K | Aug 1, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ACRS | Aclaris Therapeutics, Inc. | Aug 1, 2025 | 2 | $0 | 4 | Aug 5, 2025 | Chief Scientific Officer |
| ACRS | Aclaris Therapeutics, Inc. | Jul 28, 2025 | 0 | $0 | 3 | Aug 5, 2025 | Chief Scientific Officer |